Evan Wood, Moira McKinnon, Robert Strang, Perry R. Kendall
28 March 2012
The use of illegal drugs remains a serious threat to community health. However, despite the substantial social costs attributable to illegal drugs, a well-described discordance between scientific evidence and policy exists in this area, such that most resources go to drug law enforcement activities that have not been well evaluated. When the Office of the Auditor General of Canada last reviewed the country’s drug strategy, in 2001, it estimated that of the $454 million spent annually on efforts to control illicit drugs, $426 million (93.8%) was devoted to law enforcement.
Harm-reduction as a policy goal implies targeting directly drug-related harms rather than drug use itself. So far it has been largely a public health sector movement, focused on harms to users, most notably from heroin overdose, injection drug use and club drugs. Harm-reduction has offered fewer solutions to the problems of drug-related crime, violence, corruption or market externalities. However, harm-reduction has potentially much broader application when applied to the entire suite of harms generated by the production, distribution, consumption and control of drugs, not just drug use.